Related Experiment Video
Updated: Oct 28, 2025
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
AIDS and COVID-19 in southern Africa
Arnau van Wyngaard1, Alan Whiteside2
1Shiselweni Home-Based Care, Department of Science of Religion and Missiology, University of Pretoria, Piet Retief, South Africa.
Insights
Southern African nations effectively managed early COVID-19 cases, possibly due to lessons learned from the AIDS epidemic. This experience with HIV/AIDS informed their public health strategies for the novel coronavirus.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Early COVID-19 pandemic (February 2021) saw low reported cases and deaths in Southern Africa.
- International media questioned the low mortality rates, speculating on various factors.
- This study investigates the potential role of prior experience with the Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) epidemic.
Purpose of the Study:
- To explore whether knowledge gained from combating the AIDS epidemic influenced Southern Africa's response to COVID-19.
- To compare similarities and differences in public health approaches for both viral diseases.
Main Methods:
- Comparative analysis of public health strategies for HIV/AIDS and COVID-19 in Southern Africa.
- Review of epidemiological data and behavioral interventions for both diseases.
Main Results:
- Both HIV/AIDS and COVID-19 share similarities: zoonotic origin, lack of cure, importance of behavioral change, and vulnerable populations.
- Key differences include COVID-19's high infectivity and rapid recovery for most, versus HIV's lifelong treatment needs and lower transmission ease.
Conclusions:
- Southern Africa's experience with HIV/AIDS may have provided a foundation for a more effective response to COVID-19.
- Lessons learned from managing a chronic, widespread epidemic likely informed strategies for a novel infectious disease.
Abstract:
By the end of the first year of the COVID-19 pandemic, in February 2021, the numbers of cases and deaths in southern Africa were low in absolute and relative numbers. The BBC ran a story (which was later retracted) headlined "Coronavirus in Africa: Could poverty explain mystery of low death rate?". A heading in the New York Post said: "Scientists can't explain puzzling lack of coronavirus outbreaks in Africa". Journalist Karen Attiah concluded: "It's almost as if they are disappointed that Africans aren't dying en masse and countries are not collapsing". We wondered if the knowledge that southern African countries have acquired in their struggle against AIDS has contributed to a more effective approach against COVID-19. The viral origins of the diseases through zoonotic events are similar; neither has a cure, yet. In both diseases, behaviour change is an important prevention tool, and there are specific groups that are more vulnerable to infection. Equally, there are important differences: most people with COVID-19 will recover relatively quickly, while people living with HIV will need lifelong treatment. COVID-19 is extremely infectious, while HIV is less easily transmitted.
Related Concept Videos
01:26Sexually Transmitted Infections
01:10Retrovirus Life Cycles
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...